Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Medical Research and Opinion

• Publication date

  2009-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/03007990902864749PMID 19419344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors affecting hospitalization costs in Type 2 diabetic patients.

  2009cited by this paper
• Painful Diabetic Peripheral Neuropathy in a Managed Care Setting: Patient Identification, Prevalence Estimates, and Pharmacy Utilization Patterns

  2008cited by this paper
• Economic Costs of Diabetes in the U.S. in 2007

  2008cited by this paper
• Lost Productive Time and Costs Due to Diabetes and Diabetic Neuropathic Pain in the US Workforce

  2007cited by this paper
• Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care.

  2007cited by this paper
• Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review.

  2007cited by this paper
• Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.

  2007cited by this paper
• The natural history of chronic painful peripheral neuropathy in a community diabetes population

  2006cited by this paper
• Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

  2005cited by this paper
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005cited by this paper
• Diabetic neuropathy: an intensive review.

  2004cited by this paper
• Diabetic somatic neuropathies.

  2004cited by this paper
• Clinical characteristics and economic costs of patients with painful neuropathic disorders.

  2004cited by this paper
• Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey.

  2004cited by this paper
• Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

  2004influential reference
• Management of dyslipidemia in children and adolescents with diabetes.

  2003cited by this paper
• The direct medical cost of type 2 diabetes.

  2003cited by this paper
• The health care costs of diabetic peripheral neuropathy in the US.

  2003cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.

  2003cited by this paper
• Understanding the impact of painful diabetic neuropathy

  2003cited by this paper
• The progressive cost of complications in type 2 diabetes mellitus.

  1999cited by this paper
• Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.

  1998cited by this paper
• Pain assessment and evaluation of patients who have neuropathic pain.

  1998cited by this paper
• Epidemiology of peripheral neuropathy.

  1997cited by this paper
• Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population

  1997cited by this paper
• Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Back pain in primary care. Outcomes at 1 year.

  1993cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• Use of the International Classification of Diseases (ICD‐9‐CM) to Identify Hospitalizations for Mechanical Low Back Problems in Administrative Databases

  1992cited by this paper
• Pathways to Diabetic Limb Amputation: Basis for Prevention

  1990cited by this paper
• The Prevalence of Symptomatic, Diabetic Neuropathy in an Insulin-treated Population

  1985cited by this paper
• Estimating Regression Models with Multiplicative Heteroscedasticity

  1976cited by this paper

• Impact of Comorbidity on Hospitalization and Emergency Room Visits in Adults With Diabetes: A Longitudinal Study of Alberta's Tomorrow Project.

  2023cites this paper
• The Last Decade Publications on Diabetic Peripheral Neuropathic Pain: A Bibliometric Analysis

  2022cites this paper
• Association of chronic pain with comorbidities and health care utilization: a retrospective cohort study using health administrative data.

  2021cites this paper
• Diffculties and ways to overcome them in selection of therapy for pain syndromes in patients with diabetes mellitus

  2021cites this paper
• Anxiety, depression and sleep disorders in patients with diabetic neuropathic pain: a systematic review

  2019influential citation
• Using Random Forest Models to Identify Correlates of a Diabetic Peripheral Neuropathy Diagnosis from Electronic Health Record Data

  2017cites this paper
• Pain Management Strategies and Health Care Use in Community-Dwelling Individuals Living with Chronic Pain

  2017cites this paper
• Prevalence of Chronic Pain in a Large Integrated Healthcare Delivery System in the U.S.A

  2016cites this paper
• Roles of Voltage-Gated Tetrodotoxin-Sensitive Sodium Channels NaV1.3 and NaV1.7 in Diabetes and Painful Diabetic Neuropathy

  2016cites this paper
• Communication Barriers and the Clinical Recognition of Diabetic Peripheral Neuropathy in a Diverse Cohort of Adults: The DISTANCE Study

  2016cites this paper
• Single- Versus Multiple-Drug Pharmacotherapy in the Management of Diabetic Painful Neuropathy

  2016cites this paper
• Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States

  2016cites this paper
• Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.

  2015cites this paper
• Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

  2015cites this paper
• Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy.

  2015influential citation
• ПАТОГЕНЕТИЧЕСКАЯ ТЕРАПИЯ НЕВРОПАТИЧЕСКОЙ БОЛИ ПРИ ДИАБЕТИЧЕСКОЙ ПОЛИНЕВРОПАТИИ

  2015cites this paper
• Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events

  2015cites this paper
• Diabetic Peripheral Neuropathy: Current Concepts and Future Perspectives

  2015cites this paper
• Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?

  2014cites this paper
• Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy

  2014cites this paper
• Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional survey

  2014cites this paper
• Assessment of pain and impact of care among patients with painful diabetic peripheral neuropathy.

  2014cites this paper
• Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia.

  2014cites this paper
• Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy.

  2013cites this paper
• Painful and Painless Diabetic Neuropathy: One Disease or Two?

  2013cites this paper
• Epidemiology and Scope of Impact of Painful Diabetic Neuropathy

  2013cites this paper
• Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.

  2013cites this paper
• Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

  2013cites this paper
• Identification of Patients with Painful Diabetic Peripheral Neuropathy Who Have a Favorable Cost Profile with Pregabalin Treatment

  2013cites this paper
• Original article Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy

  2012cites this paper
• Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine

  2012cites this paper
• Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy

  2012cites this paper
• Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy.

  2012cites this paper
• Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico

  2012cites this paper
• A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost.

  2011cites this paper
• Clinical Characteristics, Pharmacotherapy, and Healthcare Resource Use among Patients with Diabetic Neuropathy Newly Prescribed Pregabalin or Gabapentin

  2011cites this paper
• Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy

  2011cites this paper
• Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients.

  2011cites this paper
• Retrospective Evaluation of Clinical Characteristics, Pharmacotherapy and Healthcare Resource Use among Patients Prescribed Pregabalin or Duloxetine for Diabetic Peripheral Neuropathy in Usual Care

  2011cites this paper
• A new model of well-child care: implications for resource costs and dissemination.

  2011cites this paper
• ANewModelofWell-ChildCare: ImplicationsforResourceCostsandDissemination

  2011cites this paper
• Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine

  2010cites this paper
• Epidemiologia e qualidade de vida em indivíduos com neuropatia diabética dolorosa: uma revisão bibliográfica

  2010cites this paper